134 related articles for article (PubMed ID: 451449)
1. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
Asbjörnsen G
Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
[TBL] [Abstract][Full Text] [Related]
2. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
Wilimas J; Thompson E; Smith KL
Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
[TBL] [Abstract][Full Text] [Related]
3. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
Margerison AC; Mann JR
Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
[TBL] [Abstract][Full Text] [Related]
4. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
[TBL] [Abstract][Full Text] [Related]
5. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
Thorling EB; Thorling K
Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
[TBL] [Abstract][Full Text] [Related]
6. Ceruloplasmin in Hodgkin's disease.
Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
[TBL] [Abstract][Full Text] [Related]
8. Serum copper in Hodgkin's disease in children.
Tessmer CF; Hrgovcic M; Wilbur J
Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
[No Abstract] [Full Text] [Related]
9. Significance of serum copper levels in adult patients with Hodgkin's disease.
Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
[No Abstract] [Full Text] [Related]
10. Classification and prognostic value of serum copper/zinc ratio in Hodgkin's disease.
Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Suling H
Biol Trace Elem Res; 2001 Nov; 83(2):133-8. PubMed ID: 11762530
[TBL] [Abstract][Full Text] [Related]
11. Value of laboratory indicators in Hodgkin's disease: preliminary results.
Ray GR; Wolf PH; Kaplan HS
Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
[No Abstract] [Full Text] [Related]
12. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
Oertel J; Gerhartz H
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
[TBL] [Abstract][Full Text] [Related]
13. Serum copper levels in non-Hodgkin's lymphoma.
Shah-Reddy I; Khilanani P; Bishop CR
Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
[TBL] [Abstract][Full Text] [Related]
14. Prognostic markers of disease activity in Hodgkin's disease.
Martinow AJ; Yuen K; Cooper IA; Matthews JP; Juneja S; Wolf M; Januszewicz H; Prince HM
Leuk Lymphoma; 1998 Apr; 29(3-4):383-9. PubMed ID: 9684935
[TBL] [Abstract][Full Text] [Related]
15. [Study of the erythrocyte sedimentation rate in patients with malignant lymphogranulosis].
LAVEDAN J
Acta Unio Int Contra Cancrum; 1952; 8(2):548-52. PubMed ID: 13007575
[No Abstract] [Full Text] [Related]
16. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
Bień E; Balcerska A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
[TBL] [Abstract][Full Text] [Related]
17. The erythrocyte sedimentation rate as a monitor for relapse in patients with previously treated Hodgkin's disease.
Le Bourgeois JP; Tubiana M
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):241-7. PubMed ID: 863759
[No Abstract] [Full Text] [Related]
18. Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease.
Wagener DJ; Haanen C
Eur J Clin Invest; 1977 Aug; 7(4):289-94. PubMed ID: 408150
[TBL] [Abstract][Full Text] [Related]
19. Nucleoli in lymphocytes of the peripheral blood in Hodgkin's disease: I. Changes in the course of the disease.
Dientsbier Z; Foltýnová V; Rezný Z; Vĕtrovcová E
Czech Med; 1978; 1(3):142-52. PubMed ID: 699718
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostics of relapse in hodgkin's disease (author's transl)].
Dietzel F; Grebe SF; Ristig W; Schmidt HG; Steckenmesser R
Med Klin; 1974 Feb; 69(7):289-92. PubMed ID: 4363084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
